Cautionary Note Regarding Forward Sample Clauses

Cautionary Note Regarding Forward. Looking Statements
Cautionary Note Regarding Forward. LOOKING STATEMENTS
Cautionary Note Regarding Forward. Looking Statements CONTACTS
Cautionary Note Regarding Forward. LOOKING INFORMATION USE OF PROCEEDS DIVIDEND POLICY
Cautionary Note Regarding Forward. Looking Statements This press release includes “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, including statements relating to our beliefs about CDC Software, Categoric Software, our expected acquisition of Categoric Software, the earnings-accretive nature thereof and the completion, effects and expected benefits thereof, our beliefs regarding the benefits of Categoric’s products to customers, our beliefs regarding our ability to integrate and leverage the products and solutions to be acquired through our proposed acquisition of Categoric, our expectations regarding the resumption of an acquisition business strategy, our expectations regarding our ability to attain future expansion and success with customers of CDC Software and Categoric, our beliefs regarding the timing and availability for any products developed, our beliefs regarding our ability to integrate Categoric technology with ours, the belief regarding the existence and success of synergies between Categoric and CDC Software and our ability to continue to provide supply chain solutions that help ensure the timely and profitable movement of product from demand to consumption and other statements that are not historical fact, the achievement of which involve risks, uncertainties or assumptions. These statements are based on management’s current expectations and are subject to risks and uncertainties and changes in circumstances. There are important factors that could cause actual results to differ materially from those anticipated in the forward looking statements including, among others: the conditions of the enterprise market, the completion of the acquisition of Categoric on favorable terms, if at all, and the ability of CDC Software and/or Categoric products to address the business requirements of the market, demand for and market acceptance of CDC Software and/or Categoric technology, and the ability of CDC Software to successfully integrate Categoric technology. Further information on risks or other factors that could cause results to differ is detailed in filings or submissions with the United States Securities and Exchange Commission made by CDC Corporation in its Annual Report for the year ended December 31, 2007 on Form 20-F filed on June 30, 2008 and amended on September 15, 2008. All forward-looking statements included in this press release are based upon information available to management as of the date of the pr...
Cautionary Note Regarding Forward. LOOKING INFORMATION
Cautionary Note Regarding Forward. LOOKING STATEMENTS ABOUT METALLA ABOUT COEUR CONTACT INFORMATION Metalla Royalty & Streaming Ltd. Coeur Mining, Inc.
Cautionary Note Regarding Forward. Looking Statements and financial indicators Agenda Strategic rationale Transaction details Implications for Merck KGaA, Darmstadt, Germany Executive Summary Back-up Continue to transform to a science and technology focused company Healthcare Delivering Life Science On track Performance Materials Managing Merck KGaA, Darmstadt, Germany is set to deliver sustainable profitable growth through innovation, clear differentiation, and value-creating portfolio management Solid performance and significant growth potential High-quality brands Growth markets Global presence Scientific heritage Strong sales force Strong product pipeline Strong team Attractive financials P&G profile Implications for combined business Transaction highlights Strong buyer: P&G committed to combine two leading and Full sale: Agreement foresees the sale of the complete Consumer Health business across 44 countries to P&G All-cash transaction: €3.4 bn all-cash disposal price will accelerate deleveraging with closing expected by the end of Q4 2018 Attractive valuation: Implicit multiples are above recent industry Key transaction details Key financial conditions Attractive valuation Comprehensive Consumer Health business Closing conditions and transaction structure Implications for 2018 financials and guidance Financials Guidance Consumer Health divestment will accelerate deleveraging and raise flexibility Strong focus on cash generation to ensure swift deleveraging
Cautionary Note Regarding Forward. LOOKING STATEMENTS WHERE YOU CAN FIND MORE INFORMATION